US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

from News-Economic Times https://ift.tt/395dq99